Production and Purification of Recombinant Antibodies from Mammalian Cells
JoVE Encyclopedia of Experiments
Immunology
0 views • 3:22 min • July 8th, 2025
Loading...
Overview
This article describes the process of producing antibodies using mammalian host cells. It outlines the steps involved in transfecting cells, culturing them, and purifying the antibodies.
Key Study Components
Area of Science
- Antibody production
- Molecular biology
- Cell culture techniques
Background
- Antibodies are essential tools in research and therapeutics.
- Producing antibodies in mammalian cells allows for proper folding and post-translational modifications.
- Transfection methods are crucial for introducing antibody genes into host cells.
- Purification processes are necessary to isolate functional antibodies from cell culture media.
Purpose of Study
- To demonstrate a protocol for antibody production in CHO cells.
- To highlight the importance of transfection and purification methods.
- To provide a detailed methodology for researchers in the field.
Methods Used
- Transfection of CHO cells with heavy and light chain antibody genes.
- Use of anti-clumping and antibacterial agents during cell culture.
- Harvesting and centrifugation of cell culture media.
- Purification of antibodies using protein A affinity chromatography.
Main Results
- Successful transfection and expression of antibody chains in CHO cells.
- Effective purification of antibodies from cell culture media.
- High cell viability maintained throughout the culture period.
- Yield of functional antibodies suitable for research applications.
Conclusions
- The protocol provides a reliable method for producing antibodies in CHO cells.
- Transfection and purification steps are critical for obtaining high-quality antibodies.
- This method can be adapted for various antibody types and applications.
Frequently Asked Questions
What are the key steps in antibody production?
The key steps include transfection of host cells, cell culture, and purification of antibodies.
Why use CHO cells for antibody production?
CHO cells provide a suitable environment for proper folding and modification of antibodies.
What is the role of the anti-clumping agent?
The anti-clumping agent promotes even distribution of transfected cells, improving growth and recovery.
How are antibodies purified from the culture media?
Antibodies are purified using protein A affinity chromatography after centrifugation and filtration.
What is the importance of maintaining cell viability?
Maintaining cell viability above 80% ensures optimal antibody production and quality.
What temperature is optimal for incubating CHO cells?
CHO cells are typically incubated at 32 to 34 degrees Celsius during culture.
Executive Industry Relevance
Recombinant antibody production in mammalian cells enables generation of fully functional therapeutic candidates with native folding and post-translational modifications. This process supports early-stage target validation by providing reliable material for binding assays and functional screening. Scalable purification workflows facilitate lead identification and preclinical de-risking through consistent antigen-specific reagent supply.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables production of antigen-specific antibodies for target engagement and pathway interrogation assays.
- Operational Value: Provides renewable source of functional immunoglobulins for epitope mapping and mechanism-of-action studies.
Screening & Assay Development
- Scientific Value: Supplies standardized antibody reagents for immunoassay development and target quantification in complex matrices.
- Operational Value: Ensures batch-to-batch consistency in affinity and specificity for high-throughput screening campaigns.
Translational & Preclinical Research
- Scientific Value: Generates therapeutic-format antibodies for pharmacokinetic and biodistribution studies in disease-relevant models.
- Operational Value: Enables dose-range finding and target saturation analysis critical for IND-enabling packages.
Pipeline & Workflow Integration
Antibody production bridges gene-level discovery to functional validation, feeding into lead identification through antigen-binding confirmation and effector function assessment.
- Discovery Biology: Supports hypothesis testing via secretion of quantifiable antigen-binding molecules into culture supernatant.
- Screening: Delivers purified immunoglobulins suitable for ELISA, SPR, and cell-based binding assays with defined sensitivity.
- Analytics: Enables titer measurement, purity assessment, and isoform characterization to inform downstream developability.
- Translational Research: Provides material for target tissue distribution studies and preclinical efficacy modeling.
- Enterprise Reuse: Establishes a platform capability adaptable across antibody formats and target classes for portfolio-wide application.
Operational & Enterprise Impact
- Scientific Value: Predictive confidence in target validation through access to natively folded, effector-competent antibodies.
- Operational Value: Standardized transfection and purification protocols improve reproducibility across projects and sites.
- Strategic Value: Reduces attrition risk by enabling early assessment of target druggability and antibody developability.
- Portfolio Impact: Informs go/no-go decisions via quantitative binding and functional data from reliable reagent supply.
Implementation Considerations
- Molecular biology expertise for vector design and transfection optimization.
- Cell culture infrastructure for suspension-adapted CHO systems and fed-batch processes.
- Analytical capacity for titer, purity, and charge variant analysis post-purification.
- Adaptation considerations for alternative hosts or expression systems based on antibody complexity.
- Contamination control requirements including antimicrobial agents and aseptic technique during scale-up.
Biopharma FAQs
Why does transfection efficiency impact antibody yield in mammalian systems?
Transfection efficiency determines the proportion of cells expressing heavy and light chain genes, directly influencing the titer of secreted antibodies into the culture medium. Higher transfection rates increase the likelihood of proper chain assembly and functional immunoglobulin formation, which is essential for generating sufficient material for downstream purification and assay use.
How does anti-clumping agent addition improve cell recovery during antibody production?
The anti-clumping agent promotes even distribution of transfected cells in culture, preventing aggregation that can lead to uneven nutrient access and reduced viability. Improved distribution supports consistent growth and maintains viability above 80%, which is critical for sustaining antibody secretion over the 10- to 11-day production period.
What role does protein A affinity chromatography play in antibody purification?
Protein A affinity chromatography selectively binds the Fc region of immunoglobulins, enabling isolation of antibodies from complex cell culture supernatant after centrifugation and filtration. Elution with low-purity buffer releases purified antibody fractions, which are then neutralized and formulated for use in binding assays or preclinical studies.
Why is maintaining cell viability above 80% important for consistent antibody production?
Cell viability above 80% ensures metabolic health and secretory capacity of the transfected CHO population, which directly affects the rate and consistency of antibody production throughout the culture cycle. Declining viability correlates with reduced transfection stability and increased proteolytic degradation, compromising yield and product quality.
How does harvesting and filtering clarified media prepare the sample for purification?
Harvesting the supernatant followed by centrifugation and 0.22-micrometer filtration removes cells, debris, and particulates that could foul the purification column or interfere with binding efficiency. Clarified media ensures homogeneous flow through the protein A resin, maximizing antibody capture and minimizing nonspecific interactions during purification.
07:44
Detection of SARS-CoV-2 Receptor-Binding Domain Antibody using a HiBiT-Based Bioreporter
Related Videos
0 Views
07:15
Preparation of Pseudo-Typed H5 Avian Influenza Viruses with Calcium Phosphate Transfection Method and Measurement of Antibody Neutralizing Activity
Related Videos
0 Views
06:53
Rapid Antibody Glycoengineering in Chinese Hamster Ovary Cells
Related Videos
0 Views
02:10
Generating Recombinant Monoclonal Antibodies From Mammalian Cell Cultures
Related Videos
0 Views
02:28
A Technique to Purify Monoclonal Antibodies Produced by Chinese Hamster Ovary Cells
Related Videos
0 Views
02:29
Antibody Production from a Batch Overgrowth Culture of Transfected Mammalian Cells
Related Videos
0 Views
03:03
An Affinity Chromatography Technique for the Purification of Monoclonal Antibodies
Related Videos
0 Views
10:32
Generation of Recombinant Human IgG Monoclonal Antibodies from Immortalized Sorted B Cells
Related Videos
0 Views
09:42
Generation of Murine Monoclonal Antibodies by Hybridoma Technology
Related Videos
0 Views
09:54
Laboratory Scale Production and Purification of a Therapeutic Antibody
Related Videos
0 Views
Last updated: 1 August 2026